Skip to main
RXST

RxSight (RXST) Stock Forecast & Price Target

RxSight (RXST) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 0%
Hold 67%
Sell 22%
Strong Sell 0%

Bulls say

RxSight Inc. reported a year-over-year increase in operating expenses, amounting to $36.4 million, which highlights the company's investment in growth strategies. The company demonstrated strong financial performance in its third-quarter report, surpassing revenue expectations and raising the midpoint of its guidance, while also increasing gross margin guidance for 2025 from 72-74% to 76-77%. Furthermore, potential upside drivers such as the growth of the light adjustable lenses (LAL) installed base, higher utilization rates, and improved margins suggest a favorable outlook for RxSight's stock.

Bears say

The financial data for RxSight Inc. indicates a declining trend in operational efficiency and revenue generation, as evidenced by a decrease in monthly utilization of light adjustable lenses (LALs) per laser delivery device (LDD) from 8.7 in the previous quarter to 8.0 in the current quarter, and a drop from 10.1 in the same quarter last year. The company has also issued guidance for fiscal year 2026 revenue that falls short of both internal and market expectations, projecting revenue of $120-135 million, which represents a decline of up to 11% year-over-year. Additionally, the anticipated impact of increased inventory costs on gross margins, coupled with a significant drop in LDD placements and overall sales volumes, raises concerns about the company's future financial stability and growth prospects.

RxSight (RXST) has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 0% recommend Buy, 67% suggest Holding, 22% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RxSight (RXST) Forecast

Analysts have given RxSight (RXST) a Hold based on their latest research and market trends.

According to 9 analysts, RxSight (RXST) has a Hold consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RxSight (RXST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.